Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

The ongoing controversy involving WuXi AppTec, a prominent Chinese pharmaceutical and biotechnology contract development and manufacturing organization (CDMO), has sent ripples through both ...